Catalyst Wire Dossier Catalyst Wire Dossier

NIPENT

pentostatin · Hospira, Inc.
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for NIPENT, covering 2009-09-22 to 2025-11-03. Get the full timeline:

Most recent: FDA Approved: NIPENT — Supplemental Application (Hospira, Inc.)

See pricing